Benzinga | Dec 17, 2021 09:35AM EST

Morgan Stanley Downgrades Bright Health Gr to Underweight, Lowers Price Target to $4

Morgan Stanley analyst Ricky Goldwasser downgrades Bright Health Gr (NYSE:BHG) from Equal-Weight to Underweight and lowers the price target from $5 to $4.